Inactivated Influenza Vaccine

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

Characterizing the Human Airway Immune Response to FluMist Vaccination

Flu Vaccine Responses in the Setting of Melanoma Treatment

An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh

The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)

Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle

Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years

Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults

Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children

Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants

Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)

Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine

A Study of a Live Intranasal Influenza Vaccine in Children With Cancer